Guest Editor
|
Guest Editor
|
6091
|
Mark I Greene
|
Full Article PDF
|
 |
|
Foreword
|
Foreword
|
6092
|
Mark I Greene
|
Full Article PDF
|
 |
|
Articles
|
HER2/Neu: mechanisms of dimerization/oligomerization
|
6093
|
Patrick J Brennan, Toru Kumogai, Alan Berezov, Ramachandran Murali & Mark I Greene
|
Abstract Full Article PDF
|
 |
Molecular mechanisms underlying ErbB2/HER2 action in breast cancer
|
6102
|
Daniel Harari & Yosef Yarden
|
Abstract Full Article PDF
|
 |
Overexpression of ErbB2 in cancer and ErbB2-targeting strategies
|
6115
|
Dihua Yu & Mien-Chie Hung
|
Abstract Full Article PDF
|
 |
Mechanisms of angiogenesis and their use in the inhibition of tumor growth and metastasis
|
6122
|
Anne Saaristo, Terhi Karpanen & Kari Alitalo
|
Abstract Full Article PDF
|
 |
Transgenic mouse models of human breast cancer
|
6130
|
John N Hutchinson & William J Muller
|
Abstract Full Article PDF
|
 |
HER2/neu antisense targeting of human breast carcinoma
|
6138
|
Haeri Roh, James A Pippin, Douglas W Green, Craig B Boswell, Christopher T Hirose, Nahush Mokadam & Jeffrey A Drebin
|
Abstract Full Article PDF
|
 |
New approaches to antibody therapy
|
6144
|
Louis M Weiner & Gregory P Adams
|
Abstract Full Article PDF
|
 |
BRCA1 and cell signaling
|
6152
|
Qiang Wang, Hongtao Zhang, Richard Fishel & Mark I Greene
|
Abstract Full Article PDF
|
 |
Lessons learned from BRCA1 and BRCA2
|
6159
|
Lei Zheng, Shang Li, Thomas G Boyer & Wen-Hwa Lee
|
Abstract Full Article PDF
|
 |
DNA polymerase stalling, sister chromatid recombination and the BRCA genes
|
6176
|
Ralph Scully, Nadine Puget & Katerina Vlasakova
|
Abstract Full Article PDF
|
 |
 |
 |